Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace You Might Also Like EnXray Raises ??2.3 Million To Fund Commercial Launch April 9, 2017 Nemaura Medical Develops Rechargeable Transmitter For Sugarbeat July 31, 2017 MD Anderson Cancer Center And BridgeBio Launch To Develop Targeted Therapy For Patients With Difficult-To-Treat Cancer October 3, 2017
MD Anderson Cancer Center And BridgeBio Launch To Develop Targeted Therapy For Patients With Difficult-To-Treat Cancer October 3, 2017
